Using our proprietary methodology, we have provided informed projections, describing the historical trends and likely growth opportunity associated with the cancer biomarkers market. As per the base case forecast scenario, the market is estimated to grow at an annualized rate of 5%, during the period 2024 to 2035. This opportunity will likely be well distributed across type of biomarker, type...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian